In humans, CD4+ TEMRA cells are seen in low frequencies in the blood (0.3–18%) compared to CD8+ TEMRA cells (10–30%) [65–69], but are associated with protective immunity, notably in COVID-19 and dengue infections [66,70,71]. Here, CD8A is linked to COVID-19.